3rd RAS/MAPK Pathway Targeted Drug Discovery Summit

Paid

The Only Global RAS Dedicated Conference is Returning in 2022 with the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit! Year on year, we are proud to unite the leading frontiers of the RAS industry to showcase expertise, technical data and pipeline updates, all geared toward accelerating the discovery and development of anti-RAS therapies.

22-24 February 2022

Healthcare

5th Neoantigen Summit Europe

Paid

For the first time in over two years, we are delighted to be reuniting the neoantigen community in person for the 5th Neoantigen Summit Europe, dedicated to the robust prediction, identification and validation of neoantigens.

26-28 April 2022

Healthcare

TCR-Based Therapies For Solid Tumors Summit

Paid

Welcome to the 3rd TCR-based Therapies for Solid Tumors Summit Advancing Engineered, Native & Bispecific TCRs to Effectively Treat Solid Tumors Do you want to gain unrivalled industry knowledge to build a first-class TCR-based therapy with high efficacy and targeting power in solid tumors? The industry-leading TCR-based Therapies for Solid Tumors S

27-29 June 2022

Healthcare

5th Annual RAS-Targeted Drug Development Summit

Paid

5th Annual RAS-Targeted Drug Development Summit
Personalizing Medicine Via Targeting Oncogenic RAS for Cancer
With the approval of the second-ever KRAS G12C inhibitor, the field can once again celebrate irrevocable proof that RAS is druggable! However, with so many KRAS G12C drugs in clinic, the field is now turning its eyes to the next gener

26-28 September 2023

Healthcare